NORTHERN TRUST CORP - AVENUE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AVENUE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$4,000
-42.9%
13,7670.0%0.00%
Q1 2022$7,000
-46.2%
13,7670.0%0.00%
Q4 2021$13,000
-38.1%
13,7670.0%0.00%
Q3 2021$21,000
-40.0%
13,7670.0%0.00%
Q2 2021$35,000
-92.5%
13,767
-82.1%
0.00%
Q1 2021$467,000
-5.1%
77,049
-6.8%
0.00%
Q4 2020$492,000
-43.9%
82,691
+2.1%
0.00%
Q3 2020$877,000
+162.6%
80,965
+161.3%
0.00%
Q2 2020$334,000
+156.9%
30,989
+112.7%
0.00%
Q1 2020$130,000
-7.1%
14,5680.0%0.00%
Q4 2019$140,000
+60.9%
14,5680.0%0.00%
Q3 2019$87,000
-5.4%
14,5680.0%0.00%
Q2 2019$92,000
+33.3%
14,5680.0%0.00%
Q1 2019$69,000
-12.7%
14,5680.0%0.00%
Q4 2018$79,00014,5680.00%
Other shareholders
AVENUE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
EMFO, LLC 24,000$12,0000.01%
Virtu Financial LLC 58,004$28,0000.00%
TWO SIGMA SECURITIES, LLC 52,813$25,0000.00%
B. Riley Wealth Advisors, Inc. 60,330$30,0000.00%
BNP PARIBAS FINANCIAL MARKETS 8$4,0000.00%
BANK OF AMERICA CORP /DE/ 104$00.00%
WELLS FARGO & COMPANY/MN 48,062$23,0000.00%
NORTHERN TRUST CORP 13,767$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 84,033$40,0000.00%
View complete list of AVENUE THERAPEUTICS INC shareholders